MDS Parkinson’s Disease Educational Course for Industry Professionals

Introduction

MDS Parkinson’s Disease Educational Course for Industry Professionals

Course Format

Regional In-Person Course

Start Date

Wed, May 25, 2022

End Date

Wed, May 25, 2022

Course Location

Hyatt Regency Miami, Miami, Florida

Program Description

The MDS Parkinson’s Disease Educational Course for Industry Professionals is a training program designed to familiarize pharmaceutical and medical device professionals with the diagnosis, treatment, and unmet needs of patients with Parkinson’s disease. The program aims to provide participants with a basic knowledge of this disorder from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.

By registering for this course, you agree to the statement provided in the section below labeled 'MUST READ: COVID-19 Disclosure Statement'.

Registration for this course is now closed. For questions, please email development@movementdisorders.org

Faculty

Course Director

Michael Okun, MD - University of Florida Fixel Institute for Neurological Diseases, Gainesville, FL, USA

Faculty

Cynthia Comella, MD, FAAN, FASM, FANA - Rush University Medical Center, New Philadelphia, OH, USA

Sarah Pirio Richardson, MD - University of New Mexico Health Sciences Center, Albuquerque, NM, USA

Carlos Singer, MD - University of Miami, Miami, FL, USA

Course Purpose

As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner.

There will be a patient/caregiver roundtable session in the program to enrich the participant’s knowledge on how PD impacts patients and their caregivers.

The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.

Registration Fees

Members: $800 USD

Non-Members: $800 USD

To view the course schedule, please click 'PROCEED TO COURSE'.

Learning Objectives

Upon completion of this activity, learners will be able to:

1. Recognize the differential diagnosis of Parkinson’s disease

2. Discuss the clinical features of Parkinson’s disease from early to advanced stages

3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery

4. Discuss non-motor features of Parkinson’s disease

5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s disease

Intended Audience

This activity is intended for industry professionals who work for pharmaceutical and medical device companies.

Course Schedule

MDS Parkinson’s Disease Educational Course for Industry Professionals
Wednesday, May 25, 2022

7:00 – 7:50	Registration and Continental Breakfast
7:50 – 8:00	Welcome and Introduction Michael Okun
8:00 – 8:45	What is Parkinson’s Disease? Pathology, Genetics, MDS Clinical Diagnostic Criteria and Initial Clinical Assessment Carlos Singer
8:45 – 9:30	Video Overview of Parkinsonian Disorders Cynthia Comella
9:30 – 9:45	Panel Q&A
9:45 – 10:00	Break
10:00 – 10:30	Progression of PD and Treatment of Early PD Sarah Pirio Richardson
10:30 – 11:00	Current Management of Advanced PD: Motor Fluctuations and Dyskinesias Cynthia Comella
11:00 – 11:30	Invasive Treatments for Parkinson’s Disease Michael Okun
11:30 – 12:00	Panel Q&A
12:00 – 13:00	Lunch
13:00 – 13:45	Non-Motor Signs and Symptoms as Parkinson’s Disease Progresses Sarah Pirio Richardson
13:45 – 14:15	Unmet Needs and Emerging Therapies for Parkinson’s Disease Michael Okun
14:15 – 14:30	Panel Q&A
14:30 – 15:00	Break
15:00 – 15:45	Patient and Caregiver Roundtable Moderators: Michael Okun and Carlos Singer
15:45 – 16:00	Interactive Discussion Moderators: Michael Okun and Carlos Singer
16:00	Adjourn

MUST READ: COVID-19 Disclosure Statement

Assumption of Risk and Liability
Attendee assumes all risks and accepts sole responsibility for any injury (including, but not limited to, personal injury, disability, and death), illness, damage, loss, claim, liability or expense, of any kind, that they may experience or incur in connection with attending the Parkinson’s Disease Educational Course for Industry Professionals.

The International Parkinson and Movement Disorder Society’s Pan American Section (MDS-PAS) has taken preventative measures to reduce the spread of communicable disease including, but not limited to COVID-19 (“Communicable Disease”) at the Parkinson’s Disease Educational Course for Industry Professionals. However, MDS cannot guarantee that attendees will not be exposed to or contract a Communicable Disease at the Parkinson’s Disease Educational Course for Industry Professionals. Further, due to the nature of the facilities, services and programs offered at the Parkinson’s Disease Educational Course for Industry Professionals, participants understand that attending the Parkinson’s Disease Educational Course for Industry Professionals could increase their risk of contracting a Communicable Disease.

Attendee agrees to abide by all applicable COVID-19-related requirements, advisories, policies, procedures, and protocols of the hotel and MDS-PAS as well as the Centers for Disease Control and Prevention (CDC), the city of Miami, the State of Florida, and any other governmental authority for the duration of their stay.

Attendee understands the risk that they may be exposed to or infected by a Communicable Disease by attending the Parkinson’s Disease Educational Course for Industry Professionals and that such exposure or infection may result in quarantine requirements, serious illness, permanent disability and/or death. Attendee further understands that the risk of becoming exposed to or infected by a Communicable Disease at the Parkinson’s Disease Educational Course for Industry Professionals may result from the actions, omissions or negligence of themselves and others, including, but not limited to, MDS-PAS, its officers, employees, contractors, agents, representatives, sponsors, other participants, and any owners and lessors of premises used to conduct the Parkinson’s Disease Educational Course for Industry Professionals (“Releasees”). ATTENDEE KNOWINGLY AND FREELY ASSUMES ALL SUCH RISKS, BOTH KNOWN AND UNKNOWN, EVEN IF ARISING FROM THE NEGLIGENCE OF THE RELEASEES, and assumes full responsibility for their participation in the Parkinson’s Disease Educational Course for Industry Professionals.

COVID-19 Vaccination
All those wishing to register for the Parkinson’s Disease Educational Course for Industry Professionals must be fully vaccinated or will be fully vaccinated by the time of the course. You may be asked for proof of this vaccination on site. If you agree to this, you may proceed with course registration. Your completion of registration serves as your agreement to this statement. For further information about our health and safety protocols, please visit our COVID-19 FAQs. Individuals unable to make this attestation are asked not to register for the course.

Registration Cancellation Policy

Registration may be cancelled up until 2 weeks before the course, minus a $25 USD cancellation fee. After this time, the registration fee is nonrefundable.

Course Location

Hyatt Regency Miami, Miami, Florida USA
Click here to view location map

Contact Us

MDS Development
development@movementdisorders.org

MDS Secretariat Liaison

Ken Buesing

Interactive Sessions

This program will take place live and in-person on Wednesday, May 25, 2022 at the Hyatt Regency Miami in Miami, FL, USA.

Visa Statement

MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official handling your application needs further clarification, please have them email development@movementdisorders.org.

MUST READ: COVID-19 Disclosure Statement

Assumption of Risk and Liability

Attendee assumes all risks and accepts sole responsibility for any injury (including, but not limited to, personal injury, disability, and death), illness, damage, loss, claim, liability or expense, of any kind, that they may experience or incur in connection with attending the Parkinson’s Disease Educational Course for Industry Professionals.

The International Parkinson and Movement Disorder Society’s Pan American Section (MDS-PAS) has taken preventative measures to reduce the spread of communicable disease including, but not limited to COVID-19 (“Communicable Disease”) at the Parkinson’s Disease Educational Course for Industry Professionals. However, MDS cannot guarantee that attendees will not be exposed to or contract a Communicable Disease at the Parkinson’s Disease Educational Course for Industry Professionals. Further, due to the nature of the facilities, services and programs offered at the Parkinson’s Disease Educational Course for Industry Professionals, participants understand that attending the Parkinson’s Disease Educational Course for Industry Professionals could increase their risk of contracting a Communicable Disease.

Attendee agrees to abide by all applicable COVID-19-related requirements, advisories, policies, procedures, and protocols of the hotel and MDS-PAS as well as the Centers for Disease Control and Prevention (CDC), the city of Miami, the State of Florida, and any other governmental authority for the duration of their stay.

Attendee understands the risk that they may be exposed to or infected by a Communicable Disease by attending the Parkinson’s Disease Educational Course for Industry Professionals and that such exposure or infection may result in quarantine requirements, serious illness, permanent disability and/or death. Attendee further understands that the risk of becoming exposed to or infected by a Communicable Disease at the Parkinson’s Disease Educational Course for Industry Professionals may result from the actions, omissions or negligence of themselves and others, including, but not limited to, MDS-PAS, its officers, employees, contractors, agents, representatives, sponsors, other participants, and any owners and lessors of premises used to conduct the Parkinson’s Disease Educational Course for Industry Professionals (“Releasees”). ATTENDEE KNOWINGLY AND FREELY ASSUMES ALL SUCH RISKS, BOTH KNOWN AND UNKNOWN, EVEN IF ARISING FROM THE NEGLIGENCE OF THE RELEASEES, and assumes full responsibility for their participation in the Parkinson’s Disease Educational Course for Industry Professionals.

COVID-19 Vaccination

All those wishing to register for the Parkinson’s Disease Educational Course for Industry Professionals must be fully vaccinated or will be fully vaccinated by the time of the course. You may be asked for proof of this vaccination on site. If you agree to this, you may proceed with course registration. Your completion of registration serves as your agreement to this statement. For further information about our health and safety protocols, please visit our COVID-19 FAQs. Individuals unable to make this attestation are asked not to register for the course.